Par, Ortho-McNeil Settle Ultracet Patent Spat
Generic drug maker Par Pharmaceuticals has admitted to infringing a patent covering the acute pain treatment Ultracet as part of a deal to resolve litigation brought by Johnson & Johnson subsidiary...To view the full article, register now.
Already a subscriber? Click here to view full article